Entries by helene

Example with LRC-TriCEPS applied to human primary T-cells

The LRC-TriCEPS  applied to human primary T-cells Zellwerk GmbH, Germany and Dualsystems Biotech AG, Zurich joined forces and conducted successfully an entire LRC- TriCEPSTM experiment on primary T-cells. Positive control ligand (included in the kit): Anti-CD28 antibody the protein CD28 Ligand of interest: Anti-TCR2 α/β antibody Cells used: human primary T-cells Read all detail from…

BioPharm America September 13–15, 2016 Boston, MA

BioPharm America September 13–15, 2016 Boston Marriott Copley Place, Boston, MA BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with Dr. Paul Helbling from Dualsystems Biotech AG to learn more about the new LRC-TriCEPSTM (Ligand-receptor capture) technology to identify targets and off-targets of your ligands on the living cells.   Please send a meeting invitation via…

BIO-Europe Conference in Stockholm/Sweden 2016, April 4-6

BIO-Europe Conference in Stockholm/Sweden 2016, April 4-6 For a face to face meeting to learn more about Dualsystems Biotech AG and its LRC-TriCEPSTM (Ligand-receptor capture – CaptiRec) technology to identify receptors of your ligand on living cells please send a meeting invitation via the conference partnering system to Dr. Paul Helbling. Alternatively, you can reach Dr.…

Dualsystems Biotech collaborates with Shantani Proteome Analytics

Dualsystems Biotech AG Press Release Dualsystems Biotech AG collaborates with Shantani Proteome Analytics Pvt. Ltd. to partner business development activities for the two companies   Schlieren, Switzerland, Feb. 2016: – Dualsystems Biotech AG has announced today it will partner with Shantani Proteome Analytics Pvt. Ltd. to support each other in business development.   The partnership…

Dualsystems on Swiss National TV

The cover story about the startup company Topadur Pharma AG is now online on Swiss National Television SRF / Eco. See Paul from #Dualsystems Biotech AG in this documentary (see at 15:38 min.)   [wuk_video]   We are lucky to have now a small biotech cluster in our building.

BIO-Europe Conference in Munich Germany 2015

BIO-Europe Conference in Munich/Germany 2015, November 2-4 For a face to face meeting to learn more about Dualsystems and its new LRC-TriCEPSTM (Ligand-receptor capture – CaptiRec) technology to identify receptors of your ligand on living cells please send a meeting invitation via the conference partnering system to Dr. Paul Helbling. Alternatively, you can reach Dr.…

CPhI Pharma Insight Briefings 13 – 15 October, Madrid, Spain

Dr. Paul Helbling is speaking at CPhI Pharma Insight Briefings. He presents the LRC-TriCEPS (CaptiRec) technology to identify the receptors of your orphan ligand on the living cells. Thursday 13th October: 10.00 – 10:45  To discuss your individual project meet Dr. Paul Helbling in person  from  10:45 – 11:30 after the presentation. Alternatively, you can reach him on…

Target Identification publication at the EBR magazine April 2015

Do you need target identification of your ligand? Ligand-receptor capture (LRC-TriCEPSTM) a new approach to find the targets in the cell membrane on the living cells. Read the article at the EBR magazine (site 25) for more details or the pdf. EBR Magazin-April-15-Dualsystems-Ligand-receptor